The residual nonadrenergic contractile response to nerve stimulation of the mouse prostate is mediated by acetylcholine but not ATP in a comparison with the mouse vas deferens

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 2, 2010, Pages 489-496

  White, Carl W ^a   Short, Jennifer L ^a   Haynes, John M ^a   Evans, Richard J ^b   Ventura, Sabatino ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ATROPINE; GUANETHIDINE; PRAZOSIN; PURINERGIC P2X1 RECEPTOR; SURAMIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; GENE DELETION; MALE; MOUSE; MUSCLE FORCE; MUSCLE ISOMETRIC CONTRACTION; NERVE STIMULATION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; SMOOTH MUSCLE CONTRACTION; VAS DEFERENS; WILD TYPE;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; ATROPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE, SMOOTH; ORGAN CULTURE TECHNIQUES; PRAZOSIN; PROSTATE; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, PURINERGIC P2X1; VAS DEFERENS;

EID: 78149255234     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.172130     Document Type: Article

References (38)

1. Arver S and Sjöstrand NO (1982) Functions of adrenergic and cholinergic nerves in canine effectors of seminal emission. Acta Physiol Scand 115:67-77.
2. Banks FC, Knight GE, Calvert RC, Thompson CS, Morgan RJ, and Burnstock G (2006) The purinergic component of human vas deferens contraction. Fertil Steril 85:932-939.
3. Buljubasich R and Ventura S (2004) Adenosine 5′-triphosphate and noradrenaline are excitatory cotransmitters to the fibromuscular stroma of the guinea pig prostate gland. Eur J Pharmacol 499:335-344.
4. Burnstock G and Verkhratsky A (2010) Vas deferens-a model used to establish sympathetic cotransmission. Trends Pharmacol Sci 31:131-139.
5. Caine M, Raz S, and Zeigler M (1975) Adrenergic and cholinergic receptors in human prostate, prostatic capsule and bladder neck. Br J Urol 47:193-202.
6. Cooper KL, McKiernan JM, and Kaplan SA (1999) α-Adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. Drugs 57:9-17.
7. Cuprian AM, Solanki P, Jackson MV, and Cunnane TC (2005) Cholinergic innervation of the mouse isolated vas deferens. Br J Pharmacol 146:927-934.
8. Deighan C, Woollhead AM, Colston JF, and McGrath JC (2004) Hepatocytes from α1B-adrenoceptor knockout mice reveal compensatory adrenoceptor subtype substitution. Br J Pharmacol 142:1031-1037.
9. Dixon JS, Jen PY, and Gosling JA (2000) The distribution of vesicular acetylcholine transporter in the human male genitourinary organs and its co-localization with neuropeptide Y and nitric oxide synthase. Neurourol Urodyn 19:185-194.
10. Fernández JL, Rivera L, López PG, Recio P, Vela-Navarrete R, and García-Sacristán A (1998) Characterization of the muscarinic receptor mediating contraction of the dog prostate. J Auton Pharmacol 18:205-211.
11. Gallegos PJ and Frazee LA (2008) Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia. Pharmacotherapy 28:356-365.
12. Gray KT and Ventura S (2005) Evaluation of the mouse prostate as a suitable model for the study of human prostate function. J Pharmacol Toxicol Methods 51:41-50.
13. 1L-Adrenoceptors mediate contractions of the isolated mouse prostate. Eur J Pharmacol 540:155-161.
14. 1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate. Br J Pharmacol 155:103-109.
15. Gup DI, Shapiro E, Baumann M, and Lepor H (1989) Contractile properties of human prostate adenomas and the development of infravesical obstruction. Prostate 15:105-114.
16. Harmar AJ, Hills RA, Rosser EM, Jones M, Buneman OP, Dunbar DR, Greenhill SD, Hale VA, Sharman JL, Bonner TI, et al. (2009) IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucl Acids Res 37:D680-D685.
17. 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig. Br J Pharmacol 122:1067-1074.
18. Haynes JM and Ventura S (2005) Current models of human prostate contractility. Clin Exp Pharmacol Physiol 32:797-804.
19. Hedlund H, Andersson KE, and Larsson B (1985) α-Adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 134:1291-1298.
20. Higgins JRA and Gosling JA (1989) Studies on the structure and intrinsic innervation of the normal human prostate. Prostate 2 (Suppl)5-16.
21. Ito Y, Oyunzul L, Seki M, Fujino Oki T, Matsui M, and Yamada S (2009) Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice. Br J Pharmacol 156:1147-1153.
22. Kester RR, Mooppan UM, Gousse AE, Alver JE, Gintautas J, Gulmi FA, Abadir AR, and Kim H (2003) Pharmacological characterization of isolated human prostate. J Urol 170:1032-1038.
23. Lau WA and Pennefather JN (1998) Muscarinic receptor subtypes in the rat prostate gland. Eur J Pharmacol 343:151-156.
24. Lau WA, Pennefather JN, and Mitchelson FJ (2000) Cholinergic facilitation of neurotransmission to the smooth muscle of the guinea-pig prostate gland. Br J Pharmacol 130:1013-1020.
25. Lau WA, Ventura S, and Pennefather JN (1998) Pharmacology of neurotransmission to the smooth muscle of the rat and the guinea-pig prostate glands. J Auton Pharmacol 18:349-356.
26. Lepor H (2007) Alpha blockers for the treatment of benign prostatic hyperplasia. Rev Urol 9:181-190.
27. Lepor H and Kuhar MJ (1984) Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue. J Urol 132:397-402. (Pubitemid 14057586)
28. Miano R, De Nunzio C, Asimakopoulos AD, Germani S, and Tubaro A (2008) Treatment options for benign prostatic hyperplasia in older men. Med Sci Monit 14:RA94-RA102.
29. 1 receptors. Nature 403:86-89.
30. Najbar-Kaszkiel AT, Di Iulio JL, Li CG, and Rand MJ (1997) Characterisation of excitatory and inhibitory transmitter systems in prostate glands of rats, guinea pigs, rabbits and pigs. Eur J Pharmacol 337:251-258.
31. Normandin DE and Lodge NJ (1996) Pharmacological characterization of the isolated canine prostate. J Urol 155:1758-1761.
32. Oki T, Maruyama S, Takagi Y, Yamamura HI, and Yamada S (2006) Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice. Eur J Pharmacol 529:157-163.
33. Rokosh DG and Simpson PC (2002) Knockout of the α 1A/C-adrenergic receptor subtype: The α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 99:9474-9479.
34. Roosen A, Blake-James BT, Wood D, and Fry CH (2009) Clinical and experimental aspects of adreno-muscarinic synergy in the bladder base and prostate. Neurourol Urodyn 28:938-943.
35. Solanki P, Cuprian-Beltechi AM, and Cunnane TC (2007) Cholinergic innervation of the guinea-pig isolated vas deferens. Naunyn Schmiedebergs Arch Pharmacol 376:265-274.
36. Ventura S, Dewalagama RK, and Lau LC (2003) Adenosine 5′-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland. Br J Pharmacol 138:1277-1284.
37. Ventura S, Pennefather J, and Mitchelson F (2002) Cholinergic innervation and function in the prostate gland. Pharmacol Ther 94:93-112.
38. Wilson JD (1980) The pathogenesis of benign prostatic hyperplasia. Am J Med 68:745-756.